Pet in oncology: Will it replace the other modalities?

Seminars in Nuclear Medicine

Volumn 27, Issue 2, 1997, Pages 94-106

  Hoh, C K ^a   Schiepers, C ^a   Seltzer, M A ^a   Gambhir, S S ^a   Silverman, D H S ^a   Czernin, J ^a   Maddahi, J ^a   Phelps, M E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID C 11; FLOXURIDINE F 18; FLUORODEOXYGLUCOSE F 18; GALLIUM EDETATE GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; WATER O 15;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030935125     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(97)80042-6     Document Type: Article

References (85)

1. Di Chiro G De la Paz RL Brooks RA Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and PET Neurology 32 1982 1323 1329
2. Di Chiro G Brooks RA Sokoloff L Glycolytic rate and histological grade of human cerebral gliomas: a study with 18F-fluorodeoxyglucose and positron emission tomography Heiss WD Phelps ME Positron Emission Tomography of the Brain 1983 Springer-Verlag New York 181 191
3. Di Chiro G Hatazawa J Katz DA Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study Radiology 164 1987 521 526
4. Di Chiro G Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors — A powerful diagnostic and prognostic tool Invest Radiol 22 1987 360 371
5. Di Chiro G Oldfield E Wright DC Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies AJR 150 1988 189 197
6. Warburg O The Metabolism of Tumors 1931 Richard R. Smith Inc New York, NY 129 169
7. Warburg O On the origins of cancer cells Science 123 1956 309 314
8. Ichiya Y Kuwabara Y Otsuka M Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography J Nucl Med 32 1991 1655 1660
9. Bloom AD Adler LP Shuck JM Determination of malignancy of thyroid nodules with positron emission tomography Surgery 114 1993 728 734
10. Sisson JC Ackermann RJ Meyer MA Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy J Clin Endocrinol Metab 77 1993 1090 1094
11. Adler LP Bloom AD Positron emission tomography of thyroid masses Thyroid 3 1993 195 200
12. Wahl RL Cody RL Hutchins G Positron emission tomographic scanning of primary and metastatic breast with the radiolabeled glucose analogue 2-deoxy-2[18F]fluoro-D-glucose N Engl J Med 324 1991 200
13. Wahl RL Cody RL Hutchins GD Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue-2-[F-18]-Fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
14. Tse NY Hoh CK Hawkins RA The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease Ann Surg 216 1992 27 34
15. Adler LP Crowe JP al-Kaisi NK Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET Radiology 187 1993 743 750
16. Nieweg OE Kim EE Wong WH Positron emission tomography with fluorine-18-deoxy-glucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
17. Paul R Comparison of fluorine-18-2 fluorodeoxyglucose and gallium 67 citrate imaging for detection of lymphoma J Nucl Med 28 1987 288 292
18. Okada J Yoshikawa K Imazeki K The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis J Nucl Med 32 1991 686 691
19. Leskinen-Kallio S Ruotsalainen U Nagren K Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study J Nucl Med 32 1991 1211 1218
20. Okada J Yoshikawa K Itami M Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity J Nucl Med 33 1992 325 329
21. Newman JS Francis IR Kaminski MS Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT Radiology 190 1994 111 116
22. Nolop KB Rhodes CG Brudin LH Glucose utilization in vivo by human pulmonary neoplasms Cancer 60 1987 2682 2689
23. Kubota K Matsuzawa T Fujiwara T Differential diagnosis of lung tumor with positron emission tomography: A prospective study J Nucl Med 31 1990 1927 1932
24. Gupta NC Frank AR Dewan NA Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 184 1992 441 444
25. Patz EF Jr Lowe VJ Hoffman JM Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
26. Hunter GJ Choi NC McLoud TC Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET J Nucl Med 34 1993 1571 1573
27. Rege SD Hoh CK Glaspy JA Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose Cancer 72 1993 82 90
28. Slosman DO Spiliopoulos A Couson F Satellite PET and lung cancer: A prospective study in surgical patients Nuc Med Commun 14 1993 955 961
29. Haberkorn U Strauss LG Reisser C Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry J Nucl Med 32 1991 1548 1555
30. Bailet JW Abemayor E Jabour BA Positron emission tomography: A new precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy Laryngoscope 102 1992 281 288
31. Rege SD Chaiken L Hoh CK Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET Radiology 189 1993 807 812
32. Reisser C Haberkorn U Strauss LG The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors J Otolaryng 22 1993 231 238
33. Haberkorn U Strauss LG Dimitrakopoulou A Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy J Nucl Med 34 1993 12 17
34. Jabour BA Choi Y Hoh CK Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation Radiology 186 1993 27 35
35. 18F]Fluoro-D-Glucose in liver metastases from colon carcinoma J Nucl Med 23 1982 1133 1137
36. Strauss LG Clorius JH Schlag P Recurrence of colorectal tumors: PET evaluation Radiology 170 1989 329
37. Gupta NC Falk PM Frank AL Pre-operative staging of colorectal carcinoma using positron emission tomography Neb Med J 78 1993 30 35
38. Goldberg MA Lee MJ Fischman AJ Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: Potential role in oncologic imaging Radiographics 13 1993 1047 1062
39. Karlan BY Hawkins R Hoh C Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma Gyn Onc 51 1993 175 181
40. Kern KA Brunetti A Norton JA Metabolic imaging of human extremity musculo-skeletal tumors by PET J Nucl Med 29 1988 181 186
41. Adler LP Blair HF Makley JT Noninvasive grading of musculo-skeletal tumors using PET J Nucl Med 32 1991 1508 1512
42. Keys JW SUV: Standard uptake or silly useless value? J Nucl Med 36 1995 1836 1839
43. Boland GW Goldberg MA Lee MJ Indeterminate adrenal mass in patients with cancer: Evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 194 1995 131 134
44. Kim CK Gupta NC Chandramouli B Standardized uptake values of FDG: Body surface area correction is preferable to body weight correction J Nucl Med 35 1994 164 167
45. Zasadny KR Wahl RL Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose variations with body weight and a method for correction Radiology 189 1993 847 850
46. Dewan NA Gupta NC Redepenning LS Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management Chest 104 1993 997 1002
47. Duhaylongsod FG Lowe VJ Patz EF Jr Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) J Thorac Cardiovasc Surg 110 1995 130 140
48. Gupta NC Maloof J Gunel E Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET J Nucl Med 37 1996 943 948
49. Knight SB Delbeke D Stewart JR Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 1996 982 988
50. Dewan NA Reeb SD Gupta NC PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis Chest 108 1995 441 446
51. Cummings SR Lillington GA Richard RJ Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach Am Rev Respir Dis 134 1986 449 452
52. Kunstaetter R Wolkove N Kreisman H The solitary pulmonary nodule. Decision analysis Med Dec Mak 5 1985 61 75
53. Inoue T Kim EE Komaki R Detecting recurrent or residual lung cancer with FDG-PET J Nucl Med 36 1995 788 793
54. Gambhir SS Hoh CK Phelps ME Decision tree sensitivity analysis for cost effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma J Nucl Med 37 1996 1428 1436
55. Schiepers C Penninckx F De Vadder N Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging Eur J Surg Oncol 21 1995 517 522
56. Beets G Penninckx F Schiepers C Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer Br J Surg 81 1994 1666 1670
57. Lai DT Fulham M Stephen MS The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver Arch Surg 131 1996 703 707
58. Braams JW Pruim J Nikkels PG Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT J Nucl Med 37 1996 897 901
59. Anzai Y Carroll WR Quint DJ Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses Radiology 200 1996 135 141
60. Ho CL Dehdashti F Griffeth LK FDG-PET evaluation of indeterminate pancreatic masses J Comput Assist Tomogr 20 1996 363 369
61. Stollfuss JC Glatting G Friess H 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: Value of quantitative image interpretation Radiology 195 1995 339 344
62. Inokuma T Tamaki N Torizuka T Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: Comparison with CT and US Radiology 195 1995 345 352
63. Bares R Klever P Hauptmann S F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer Radiology 192 1994 79 86
64. Dahlbom M Hoffman EJ Hoh CK Evaluation of a positron emission tomography scanner for whole body imaging J Nucl Med 33 1992 1191 1199
65. Hoh CK Hawkins RA Glaspy JA Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose J Comput Assist Tomogr 17 1993 582 589
66. Hoh CK Hawkins RA Dahlbom M Whole body skeletal imaging with [18F]Fluoride Ion and PET J Comput Assist Tomogr 17 1993 34 41
67. Wahl RL Quint LE Greenough RL Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation Radiology 191 1994 371 377
68. Chin R Jr Ward R Keyes JW Mediastinal staging of non-small-cell lung cancer with positron emission tomography Am J Resp Crit Care Med 152 1995 2090 2096
69. Sasaki M Ichiya Y Kuwabara Y The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: A comparative study with X-ray computed tomography Eur J Nucl Med 23 1996 741 747
70. Hoh CK, Glaspy J, Rosen PJ et al. Whole body FDG PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med (in press)
71. Moon DH Hoh CK Silverman DS Accuracy of whole body FDG PET for the detection of recurrent or metastatic breast carcinoma J Nucl Med 37 1996 99P
72. Gritters LS Francis IR Zasadny KR Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma J Nucl Med 34 1993 1420 1427
73. Shreve PD Grossman HB Gross MD Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose Radiology 199 1996 751 756
74. Yeh SDJ Imbriaco M Garza D Twenty percent of bony metastases of hormone resistant prostate cancer are detected by PET-FDG whole body scanning J Nucl Med 36 1995 198P
75. Yao WJ Hoh CK Hawkins RA Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines J Nucl Med 36 1995 794 799
76. Effert PJ Bares R Handt S Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxy-glucose J Urol 155 1996 994 998
77. Casey MJ Gupta NC Muths CK Experience with positron emission tomography (PET) scans in patients with ovarian cancer Gyn Onc 53 1994 331 338
78. Hubner KF McDonald TW Niethammer JG Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxy-glucose (2-[18F]FDG Gyn Onc 51 1993 197 204
79. Findlay M Young H Cunningham D Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil J Clin Onc 14 1996 700 708
80. Torizuka T Tamaki N Inokuma T Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy J Nucl Med 35 1994 1965 1969
81. Haberkorn U Strauss LG Dimitrakopoulou A Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy J Nucl Med 34 1993 12 17
82. Wahl RL Zasadny K Helvie M Metabolic monitoring of breast cancer chemohormonotherapy using positron emission, tomography: Initial evaluation J Clin Onc 11 1993 2101 2111
83. Nagata Y Yamamoto K Hiraoka M Monitoring liver tumor therapy with [18F]FDG positron emission tomography J Comput Assist Tomogr 14 1990 370 374
84. Haberkorn U Strauss LG Dimitrakopoulou A PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy J Nucl Med 32 1991 1485 1490
85. Ichiya Y Kuwabara Y Otsuka M Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography J Nucl Med 32 1991 1655 1660